

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinization (GO:0031424) | 5.99424013 |
| 2 | definitive hemopoiesis (GO:0060216) | 5.69602596 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.13326019 |
| 4 | megakaryocyte development (GO:0035855) | 4.75875687 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.75429433 |
| 6 | platelet dense granule organization (GO:0060155) | 4.67938635 |
| 7 | glutamate secretion (GO:0014047) | 4.66512407 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 4.38491964 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.38491964 |
| 10 | synaptic vesicle maturation (GO:0016188) | 4.32570266 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.22244532 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 4.11656742 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.11656742 |
| 14 | establishment of skin barrier (GO:0061436) | 4.11387655 |
| 15 | sodium ion export (GO:0071436) | 3.93575387 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.92179545 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.92179545 |
| 18 | endothelium development (GO:0003158) | 3.87084222 |
| 19 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.87076310 |
| 20 | desmosome organization (GO:0002934) | 3.86667615 |
| 21 | L-fucose catabolic process (GO:0042355) | 3.84056391 |
| 22 | fucose catabolic process (GO:0019317) | 3.84056391 |
| 23 | L-fucose metabolic process (GO:0042354) | 3.84056391 |
| 24 | cellular potassium ion homeostasis (GO:0030007) | 3.77539260 |
| 25 | regulation of water loss via skin (GO:0033561) | 3.71606250 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 3.68712686 |
| 27 | peptide cross-linking (GO:0018149) | 3.66771267 |
| 28 | positive regulation of respiratory burst (GO:0060267) | 3.58323028 |
| 29 | drug transmembrane transport (GO:0006855) | 3.55320517 |
| 30 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.49790909 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.49224434 |
| 32 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.46944283 |
| 33 | ethanol oxidation (GO:0006069) | 3.43141583 |
| 34 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.39190997 |
| 35 | myelin maintenance (GO:0043217) | 3.34919266 |
| 36 | positive regulation of synapse maturation (GO:0090129) | 3.34718722 |
| 37 | regulation of synapse structural plasticity (GO:0051823) | 3.32548212 |
| 38 | cysteine metabolic process (GO:0006534) | 3.30275917 |
| 39 | multicellular organismal water homeostasis (GO:0050891) | 3.29768969 |
| 40 | response to mercury ion (GO:0046689) | 3.28776247 |
| 41 | angiogenesis involved in wound healing (GO:0060055) | 3.28558878 |
| 42 | regulation of synapse maturation (GO:0090128) | 3.26875877 |
| 43 | thrombin receptor signaling pathway (GO:0070493) | 3.25764006 |
| 44 | neuronal ion channel clustering (GO:0045161) | 3.23826191 |
| 45 | secretory granule organization (GO:0033363) | 3.21975516 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.21966398 |
| 47 | mature B cell differentiation involved in immune response (GO:0002313) | 3.20410584 |
| 48 | phospholipid scrambling (GO:0017121) | 3.18405255 |
| 49 | neurotransmitter secretion (GO:0007269) | 3.16992554 |
| 50 | positive regulation of Rap GTPase activity (GO:0032854) | 3.16683704 |
| 51 | ribosomal small subunit assembly (GO:0000028) | 3.15070877 |
| 52 | cholesterol catabolic process (GO:0006707) | 3.15012893 |
| 53 | sterol catabolic process (GO:0016127) | 3.15012893 |
| 54 | L-amino acid import (GO:0043092) | 3.11382366 |
| 55 | vocalization behavior (GO:0071625) | 3.11215872 |
| 56 | aromatic amino acid family catabolic process (GO:0009074) | 3.09129296 |
| 57 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.07633532 |
| 58 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.05957188 |
| 59 | Peyers patch development (GO:0048541) | 3.05957188 |
| 60 | membrane tubulation (GO:0097320) | 3.04627168 |
| 61 | citrulline biosynthetic process (GO:0019240) | 3.03854818 |
| 62 | toxin transport (GO:1901998) | 3.02841001 |
| 63 | valine metabolic process (GO:0006573) | 3.02040811 |
| 64 | embryonic hemopoiesis (GO:0035162) | 3.01589160 |
| 65 | dendritic spine morphogenesis (GO:0060997) | 3.01585279 |
| 66 | bile acid biosynthetic process (GO:0006699) | 3.00494264 |
| 67 | drug transport (GO:0015893) | 3.00257336 |
| 68 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.97948853 |
| 69 | cell volume homeostasis (GO:0006884) | 2.96212224 |
| 70 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.96111059 |
| 71 | keratinocyte differentiation (GO:0030216) | 2.95948079 |
| 72 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.95806632 |
| 73 | blood coagulation, intrinsic pathway (GO:0007597) | 2.95023193 |
| 74 | cerebellar granule cell differentiation (GO:0021707) | 2.92761976 |
| 75 | regulation of ARF protein signal transduction (GO:0032012) | 2.91115969 |
| 76 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.90938694 |
| 77 | lysine metabolic process (GO:0006553) | 2.90738001 |
| 78 | lysine catabolic process (GO:0006554) | 2.90738001 |
| 79 | dendritic spine organization (GO:0097061) | 2.89354379 |
| 80 | glutamate metabolic process (GO:0006536) | 2.87641919 |
| 81 | regulation of synaptic vesicle transport (GO:1902803) | 2.87532950 |
| 82 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.86486709 |
| 83 | very long-chain fatty acid metabolic process (GO:0000038) | 2.83428647 |
| 84 | heparin biosynthetic process (GO:0030210) | 2.82112109 |
| 85 | heparin metabolic process (GO:0030202) | 2.82112109 |
| 86 | glomerular filtration (GO:0003094) | 2.81696129 |
| 87 | regulation of triglyceride catabolic process (GO:0010896) | 2.81002381 |
| 88 | mesodermal cell differentiation (GO:0048333) | 2.80469452 |
| 89 | semaphorin-plexin signaling pathway (GO:0071526) | 2.80184546 |
| 90 | response to interferon-beta (GO:0035456) | 2.79607849 |
| 91 | renal filtration (GO:0097205) | 2.78947162 |
| 92 | cell-cell junction maintenance (GO:0045217) | 2.78839899 |
| 93 | cell communication involved in cardiac conduction (GO:0086065) | 2.78399426 |
| 94 | hemidesmosome assembly (GO:0031581) | 2.77389680 |
| 95 | heme transport (GO:0015886) | 2.77286408 |
| 96 | regulation of respiratory burst (GO:0060263) | 2.77084430 |
| 97 | adenosine receptor signaling pathway (GO:0001973) | 2.77081359 |
| 98 | creatine metabolic process (GO:0006600) | 2.76454147 |
| 99 | response to interferon-alpha (GO:0035455) | 2.75942223 |
| 100 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.75726750 |
| 101 | opsonization (GO:0008228) | 2.73842196 |
| 102 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.72167840 |
| 103 | glyoxylate metabolic process (GO:0046487) | 2.71637878 |
| 104 | negative regulation of viral entry into host cell (GO:0046597) | 2.71580832 |
| 105 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.71249814 |
| 106 | water homeostasis (GO:0030104) | 2.70260647 |
| 107 | tricarboxylic acid metabolic process (GO:0072350) | 2.70110291 |
| 108 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.69829959 |
| 109 | regulation of erythrocyte differentiation (GO:0045646) | 2.68871103 |
| 110 | surfactant homeostasis (GO:0043129) | 2.68612312 |
| 111 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.67447485 |
| 112 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.67061955 |
| 113 | amino acid import (GO:0043090) | 2.66597591 |
| 114 | dopamine receptor signaling pathway (GO:0007212) | 2.65931769 |
| 115 | regulation of Rap GTPase activity (GO:0032317) | 2.65559097 |
| 116 | quaternary ammonium group transport (GO:0015697) | 2.64691051 |
| 117 | phosphate ion transmembrane transport (GO:0035435) | 2.63599649 |
| 118 | regulation of axon regeneration (GO:0048679) | 2.63351971 |
| 119 | regulation of neuron projection regeneration (GO:0070570) | 2.63351971 |
| 120 | locomotory exploration behavior (GO:0035641) | 2.62819055 |
| 121 | epidermal cell differentiation (GO:0009913) | 2.61359626 |
| 122 | metanephric nephron epithelium development (GO:0072243) | 2.61196198 |
| 123 | layer formation in cerebral cortex (GO:0021819) | 2.60829201 |
| 124 | renal absorption (GO:0070293) | 2.58879116 |
| 125 | negative regulation of lipase activity (GO:0060192) | 2.58617047 |
| 126 | cell migration in hindbrain (GO:0021535) | 2.58201587 |
| 127 | positive regulation of B cell differentiation (GO:0045579) | 2.58070227 |
| 128 | potassium ion homeostasis (GO:0055075) | 2.57906200 |
| 129 | neuromuscular process controlling balance (GO:0050885) | 2.57813525 |
| 130 | amino-acid betaine metabolic process (GO:0006577) | 2.56877653 |
| 131 | 2-oxoglutarate metabolic process (GO:0006103) | 2.55891070 |
| 132 | regulation of natural killer cell differentiation (GO:0032823) | 2.55189357 |
| 133 | growth hormone receptor signaling pathway (GO:0060396) | 2.53919462 |
| 134 | regulation of synaptic plasticity (GO:0048167) | 2.53671640 |
| 135 | urate metabolic process (GO:0046415) | 2.53639094 |
| 136 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.53111931 |
| 137 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.53111931 |
| 138 | regulation of triglyceride metabolic process (GO:0090207) | 2.53108049 |
| 139 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.52396886 |
| 140 | kynurenine metabolic process (GO:0070189) | 2.52090418 |
| 141 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.51862781 |
| 142 | iron coordination entity transport (GO:1901678) | 2.51527330 |
| 143 | carnitine shuttle (GO:0006853) | 2.50764511 |
| 144 | activation of protein kinase A activity (GO:0034199) | 2.50507565 |
| 145 | regulation of ARF GTPase activity (GO:0032312) | 2.50281399 |
| 146 | branched-chain amino acid metabolic process (GO:0009081) | 2.49614687 |
| 147 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.48822231 |
| 148 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.48049716 |
| 149 | regulation of cholesterol metabolic process (GO:0090181) | 2.47872611 |
| 150 | sulfur amino acid catabolic process (GO:0000098) | 2.47822706 |
| 151 | myeloid cell development (GO:0061515) | 2.47631427 |
| 152 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.45928541 |
| 153 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.45617127 |
| 154 | neurotransmitter transport (GO:0006836) | 2.44788812 |
| 155 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.44202050 |
| 156 | negative regulation of fibrinolysis (GO:0051918) | 2.43420710 |
| 157 | aspartate family amino acid catabolic process (GO:0009068) | 2.43176177 |
| 158 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.42902095 |
| 159 | flavonoid metabolic process (GO:0009812) | 2.42888751 |
| 160 | potassium ion import (GO:0010107) | 2.42842175 |
| 161 | cellular sodium ion homeostasis (GO:0006883) | 2.42728133 |
| 162 | mannose metabolic process (GO:0006013) | 2.42659083 |
| 163 | bile acid metabolic process (GO:0008206) | 2.41722827 |
| 164 | fatty acid elongation (GO:0030497) | 2.41603995 |
| 165 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.40935523 |
| 166 | metanephric epithelium development (GO:0072207) | 2.40514971 |
| 167 | short-chain fatty acid metabolic process (GO:0046459) | 2.40442695 |
| 168 | fatty acid transmembrane transport (GO:1902001) | 2.40398224 |
| 169 | positive regulation of Rac GTPase activity (GO:0032855) | 2.39785056 |
| 170 | axon ensheathment in central nervous system (GO:0032291) | 2.39176283 |
| 171 | central nervous system myelination (GO:0022010) | 2.39176283 |
| 172 | negative regulation of bone mineralization (GO:0030502) | 2.38471529 |
| 173 | granulocyte differentiation (GO:0030851) | 2.37901362 |
| 174 | arginine metabolic process (GO:0006525) | 2.37707910 |
| 175 | cell communication by electrical coupling (GO:0010644) | 2.36718368 |
| 176 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.35319539 |
| 177 | regulation of neurotransmitter levels (GO:0001505) | 2.35205863 |
| 178 | regulation of female receptivity (GO:0045924) | 2.33001451 |
| 179 | cell junction maintenance (GO:0034331) | 2.32831205 |
| 180 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.29903203 |
| 181 | positive regulation of dendritic spine development (GO:0060999) | 2.28112305 |
| 182 | regulation of p38MAPK cascade (GO:1900744) | 2.28094262 |
| 183 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.27811299 |
| 184 | regulation of vesicle fusion (GO:0031338) | 2.27554979 |
| 185 | phosphate ion transport (GO:0006817) | 2.27512290 |
| 186 | cardiac conduction (GO:0061337) | 2.27416688 |
| 187 | actin filament capping (GO:0051693) | 2.23152690 |
| 188 | activation of Rac GTPase activity (GO:0032863) | 2.21791060 |
| 189 | chemical homeostasis within a tissue (GO:0048875) | 2.20402220 |
| 190 | neuron remodeling (GO:0016322) | 2.20035085 |
| 191 | endothelial cell chemotaxis (GO:0035767) | 2.20000297 |
| 192 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.19860971 |
| 193 | positive regulation of membrane potential (GO:0045838) | 2.19340781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 5.60375440 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.98301675 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.87050379 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.50276571 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.32643818 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.00379253 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.92035476 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.80975884 |
| 9 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.64374835 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.63917353 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54839663 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.48581518 |
| 13 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.43655274 |
| 14 | GATA1_19941826_ChIP-Seq_K562_Human | 2.43017416 |
| 15 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42939615 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.22889292 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.17173460 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.04454791 |
| 19 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.03571682 |
| 20 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.98707496 |
| 21 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.95270427 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92765706 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92224234 |
| 24 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.87345169 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.85224964 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84001452 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.82291549 |
| 28 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.81454846 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79240099 |
| 30 | GATA2_19941826_ChIP-Seq_K562_Human | 1.78527889 |
| 31 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.78275199 |
| 32 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78156581 |
| 33 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.75069480 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.69975803 |
| 35 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.68055594 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.66901551 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.66260655 |
| 38 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65589140 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.65034627 |
| 40 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.64362983 |
| 41 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.64275812 |
| 42 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58762326 |
| 43 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.54737525 |
| 44 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54714195 |
| 45 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.52994032 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.52570830 |
| 47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52016080 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.51344826 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48920184 |
| 50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.47990400 |
| 51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.47307444 |
| 52 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.47128381 |
| 53 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.46474243 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.44835570 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.44289497 |
| 56 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43393156 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.42197043 |
| 58 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.41053230 |
| 59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.40950519 |
| 60 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.40950519 |
| 61 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.40632269 |
| 62 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.40375631 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.38572623 |
| 64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36828457 |
| 65 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34176663 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34037840 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33533954 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33204948 |
| 69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31124629 |
| 70 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.29997499 |
| 71 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29710148 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29228166 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27817755 |
| 74 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.27402922 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26585685 |
| 76 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.26379972 |
| 77 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25692226 |
| 78 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25319691 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24631180 |
| 80 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.24252420 |
| 81 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24124659 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23638430 |
| 83 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22878613 |
| 84 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.20862158 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20809900 |
| 86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20502548 |
| 87 | * MAF_26560356_Chip-Seq_TH1_Human | 1.18351157 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17579312 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16802143 |
| 90 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.16237649 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16007821 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15504469 |
| 93 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15275023 |
| 94 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.15264927 |
| 95 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.15223208 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.14228239 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13624328 |
| 98 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13457103 |
| 99 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13175165 |
| 100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.12621200 |
| 101 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.12495213 |
| 102 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.12162752 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10947986 |
| 104 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10171824 |
| 105 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09553343 |
| 106 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08882185 |
| 107 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07851819 |
| 108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06270709 |
| 109 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05672490 |
| 110 | * P68_20966046_ChIP-Seq_HELA_Human | 1.05352345 |
| 111 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05114564 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04497355 |
| 113 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.02963031 |
| 114 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02270943 |
| 115 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02176612 |
| 116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02107410 |
| 117 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01724396 |
| 118 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00378027 |
| 119 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00298017 |
| 120 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00287631 |
| 121 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98971923 |
| 122 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98859037 |
| 123 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98392950 |
| 124 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.98116400 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.97899991 |
| 126 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97815076 |
| 127 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97030162 |
| 128 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.96769519 |
| 129 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96724376 |
| 130 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.95391919 |
| 131 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95039893 |
| 132 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.94982102 |
| 133 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.94671213 |
| 134 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94628435 |
| 135 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94591076 |
| 136 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.94443986 |
| 137 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94238693 |
| 138 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.93816307 |
| 139 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93457961 |
| 140 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92188177 |
| 141 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91384839 |
| 142 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90943781 |
| 143 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.89775727 |
| 144 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88190355 |
| 145 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88024150 |
| 146 | UTX_26944678_Chip-Seq_JUKART_Human | 0.86877699 |
| 147 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85619313 |
| 148 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.85033142 |
| 149 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84033578 |
| 150 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.83838960 |
| 151 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83611595 |
| 152 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83188640 |
| 153 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.82937891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.24265497 |
| 2 | MP0010368_abnormal_lymphatic_system | 3.90908360 |
| 3 | MP0005360_urolithiasis | 3.54602673 |
| 4 | MP0004147_increased_porphyrin_level | 3.35506363 |
| 5 | MP0005365_abnormal_bile_salt | 3.27109484 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.24954665 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.97301511 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.75204288 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.71666118 |
| 10 | MP0000465_gastrointestinal_hemorrhage | 2.63941387 |
| 11 | MP0003252_abnormal_bile_duct | 2.60741379 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.59932171 |
| 13 | MP0005167_abnormal_blood-brain_barrier | 2.52818703 |
| 14 | MP0005083_abnormal_biliary_tract | 2.49038725 |
| 15 | MP0004270_analgesia | 2.39216710 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.33775397 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.33438674 |
| 18 | MP0001188_hyperpigmentation | 2.31355523 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.23795252 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.23663551 |
| 21 | MP0001545_abnormal_hematopoietic_system | 2.21775016 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 2.21775016 |
| 23 | MP0004782_abnormal_surfactant_physiolog | 2.13688227 |
| 24 | MP0003880_abnormal_central_pattern | 2.12896644 |
| 25 | MP0002396_abnormal_hematopoietic_system | 2.12176568 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 2.08676067 |
| 27 | MP0004043_abnormal_pH_regulation | 2.03776467 |
| 28 | MP0009840_abnormal_foam_cell | 1.99011022 |
| 29 | MP0010329_abnormal_lipoprotein_level | 1.98045162 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.95697772 |
| 31 | MP0001879_abnormal_lymphatic_vessel | 1.90451480 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.90130725 |
| 33 | MP0004859_abnormal_synaptic_plasticity | 1.89616511 |
| 34 | MP0002064_seizures | 1.87537349 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.84753128 |
| 36 | MP0003868_abnormal_feces_composition | 1.82290526 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 1.79202419 |
| 38 | MP0003879_abnormal_hair_cell | 1.78934490 |
| 39 | MP0005275_abnormal_skin_tensile | 1.73484245 |
| 40 | MP0002796_impaired_skin_barrier | 1.71869278 |
| 41 | MP0005670_abnormal_white_adipose | 1.69672983 |
| 42 | MP0002063_abnormal_learning/memory/cond | 1.67898902 |
| 43 | MP0001486_abnormal_startle_reflex | 1.60743104 |
| 44 | MP0006054_spinal_hemorrhage | 1.60240267 |
| 45 | MP0005409_darkened_coat_color | 1.57770500 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.57365052 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56029224 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.55418803 |
| 49 | MP0004130_abnormal_muscle_cell | 1.54785592 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.54564161 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.51583059 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.50988853 |
| 53 | MP0009278_abnormal_bone_marrow | 1.49396387 |
| 54 | MP0002272_abnormal_nervous_system | 1.44285277 |
| 55 | MP0001968_abnormal_touch/_nociception | 1.43484710 |
| 56 | MP0002098_abnormal_vibrissa_morphology | 1.43045416 |
| 57 | MP0000579_abnormal_nail_morphology | 1.41442624 |
| 58 | MP0000566_synostosis | 1.39128645 |
| 59 | MP0000920_abnormal_myelination | 1.37228298 |
| 60 | MP0003075_altered_response_to | 1.35920101 |
| 61 | MP0009745_abnormal_behavioral_response | 1.34453793 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.33488851 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.31036366 |
| 64 | MP0004885_abnormal_endolymph | 1.30798795 |
| 65 | MP0005375_adipose_tissue_phenotype | 1.28905121 |
| 66 | MP0001765_abnormal_ion_homeostasis | 1.26507658 |
| 67 | MP0000747_muscle_weakness | 1.25862139 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.25116613 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.24422707 |
| 70 | MP0003943_abnormal_hepatobiliary_system | 1.24411089 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.24155324 |
| 72 | MP0001986_abnormal_taste_sensitivity | 1.23773572 |
| 73 | MP0005501_abnormal_skin_physiology | 1.23606486 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 1.23482499 |
| 75 | MP0003690_abnormal_glial_cell | 1.22316969 |
| 76 | MP0005332_abnormal_amino_acid | 1.22161469 |
| 77 | MP0002733_abnormal_thermal_nociception | 1.19645460 |
| 78 | MP0002734_abnormal_mechanical_nocicepti | 1.19514495 |
| 79 | MP0001970_abnormal_pain_threshold | 1.19053135 |
| 80 | MP0010678_abnormal_skin_adnexa | 1.18747548 |
| 81 | MP0001756_abnormal_urination | 1.15864670 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 1.15168293 |
| 83 | MP0002822_catalepsy | 1.15127607 |
| 84 | MP0003638_abnormal_response/metabolism_ | 1.14766867 |
| 85 | MP0000467_abnormal_esophagus_morphology | 1.12424048 |
| 86 | MP0003303_peritoneal_inflammation | 1.12397485 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 1.11611939 |
| 88 | MP0000609_abnormal_liver_physiology | 1.11345598 |
| 89 | MP0008874_decreased_physiological_sensi | 1.11234843 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 1.11195031 |
| 91 | MP0009643_abnormal_urine_homeostasis | 1.09012970 |
| 92 | MP0003566_abnormal_cell_adhesion | 1.08655227 |
| 93 | MP0005535_abnormal_body_temperature | 1.05271373 |
| 94 | MP0005220_abnormal_exocrine_pancreas | 1.04141384 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 1.01161878 |
| 96 | MP0003045_fibrosis | 1.00998161 |
| 97 | MP0001216_abnormal_epidermal_layer | 1.00362306 |
| 98 | MP0009379_abnormal_foot_pigmentation | 0.99738602 |
| 99 | MP0003329_amyloid_beta_deposits | 0.99571889 |
| 100 | MP0003866_abnormal_defecation | 0.98037417 |
| 101 | MP0008569_lethality_at_weaning | 0.97315984 |
| 102 | MP0004036_abnormal_muscle_relaxation | 0.95218874 |
| 103 | MP0003724_increased_susceptibility_to | 0.94678635 |
| 104 | MP0003172_abnormal_lysosome_physiology | 0.94418005 |
| 105 | MP0009046_muscle_twitch | 0.94043619 |
| 106 | MP0001664_abnormal_digestion | 0.93205503 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.91121801 |
| 108 | MP0001177_atelectasis | 0.90479447 |
| 109 | MP0000598_abnormal_liver_morphology | 0.89963333 |
| 110 | MP0002735_abnormal_chemical_nociception | 0.89309539 |
| 111 | MP0010155_abnormal_intestine_physiology | 0.87552997 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.87089976 |
| 113 | MP0005174_abnormal_tail_pigmentation | 0.86990368 |
| 114 | MP0002928_abnormal_bile_duct | 0.86632000 |
| 115 | MP0004264_abnormal_extraembryonic_tissu | 0.85573787 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.85202576 |
| 117 | MP0001873_stomach_inflammation | 0.84372703 |
| 118 | MP0000681_abnormal_thyroid_gland | 0.82953510 |
| 119 | MP0003631_nervous_system_phenotype | 0.82827070 |
| 120 | MP0005165_increased_susceptibility_to | 0.81613096 |
| 121 | MP0003634_abnormal_glial_cell | 0.80962311 |
| 122 | MP0006138_congestive_heart_failure | 0.78894027 |
| 123 | MP0000383_abnormal_hair_follicle | 0.76185938 |
| 124 | MP0004381_abnormal_hair_follicle | 0.76128224 |
| 125 | MP0000678_abnormal_parathyroid_gland | 0.76081653 |
| 126 | MP0004947_skin_inflammation | 0.75640180 |
| 127 | MP0008961_abnormal_basal_metabolism | 0.74818021 |
| 128 | MP0009931_abnormal_skin_appearance | 0.74639142 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.74582166 |
| 130 | MP0000685_abnormal_immune_system | 0.73623219 |
| 131 | MP0008469_abnormal_protein_level | 0.73505091 |
| 132 | MP0001905_abnormal_dopamine_level | 0.72585276 |
| 133 | MP0010771_integument_phenotype | 0.72501059 |
| 134 | MP0005166_decreased_susceptibility_to | 0.71850144 |
| 135 | MP0000749_muscle_degeneration | 0.71081104 |
| 136 | MP0001881_abnormal_mammary_gland | 0.69914679 |
| 137 | MP0001440_abnormal_grooming_behavior | 0.68094884 |
| 138 | MP0000751_myopathy | 0.68074687 |
| 139 | MP0001849_ear_inflammation | 0.67933012 |
| 140 | MP0009764_decreased_sensitivity_to | 0.67699268 |
| 141 | MP0002066_abnormal_motor_capabilities/c | 0.67636944 |
| 142 | MP0002234_abnormal_pharynx_morphology | 0.66953156 |
| 143 | MP0003633_abnormal_nervous_system | 0.66728344 |
| 144 | MP0002128_abnormal_blood_circulation | 0.66557057 |
| 145 | MP0000462_abnormal_digestive_system | 0.65845446 |
| 146 | MP0000377_abnormal_hair_follicle | 0.64789511 |
| 147 | MP0009642_abnormal_blood_homeostasis | 0.64649872 |
| 148 | MP0004811_abnormal_neuron_physiology | 0.64398212 |
| 149 | MP0010352_gastrointestinal_tract_polyps | 0.63427856 |
| 150 | MP0004185_abnormal_adipocyte_glucose | 0.63132663 |
| 151 | MP0002971_abnormal_brown_adipose | 0.63108249 |
| 152 | MP0005666_abnormal_adipose_tissue | 0.62852598 |
| 153 | MP0002133_abnormal_respiratory_system | 0.62428184 |
| 154 | MP0001851_eye_inflammation | 0.62235011 |
| 155 | MP0001663_abnormal_digestive_system | 0.61499431 |
| 156 | MP0005025_abnormal_response_to | 0.60568472 |
| 157 | MP0008873_increased_physiological_sensi | 0.60383947 |
| 158 | MP0000249_abnormal_blood_vessel | 0.58865073 |
| 159 | MP0008872_abnormal_physiological_respon | 0.58693924 |
| 160 | MP0000343_altered_response_to | 0.58496064 |
| 161 | MP0009763_increased_sensitivity_to | 0.58133174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.48389673 |
| 2 | Prolonged bleeding time (HP:0003010) | 4.28017240 |
| 3 | Impaired platelet aggregation (HP:0003540) | 4.24634775 |
| 4 | Abnormal platelet function (HP:0011869) | 4.24634775 |
| 5 | Obstructive sleep apnea (HP:0002870) | 4.21608423 |
| 6 | Petechiae (HP:0000967) | 3.93568167 |
| 7 | Thrombocytosis (HP:0001894) | 3.86808184 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.70734199 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.59522084 |
| 10 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.57155884 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 3.45710661 |
| 12 | Annular pancreas (HP:0001734) | 3.34634180 |
| 13 | Epistaxis (HP:0000421) | 3.33223970 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.27883378 |
| 15 | Abnormality of nail color (HP:0100643) | 3.26720959 |
| 16 | Hyperactive renin-angiotensin system (HP:0000841) | 3.25390592 |
| 17 | Menorrhagia (HP:0000132) | 3.21514203 |
| 18 | Polycythemia (HP:0001901) | 3.19933960 |
| 19 | Gingival bleeding (HP:0000225) | 3.13991099 |
| 20 | Chronic otitis media (HP:0000389) | 3.11366292 |
| 21 | Purpura (HP:0000979) | 3.06624193 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.02269065 |
| 23 | Acanthocytosis (HP:0001927) | 3.02164258 |
| 24 | Gout (HP:0001997) | 2.98095723 |
| 25 | Distal lower limb amyotrophy (HP:0008944) | 2.92107520 |
| 26 | Abnormal platelet volume (HP:0011876) | 2.89096048 |
| 27 | Increased mean platelet volume (HP:0011877) | 2.86631129 |
| 28 | Akinesia (HP:0002304) | 2.84605596 |
| 29 | Action tremor (HP:0002345) | 2.83478342 |
| 30 | Thin bony cortex (HP:0002753) | 2.73735053 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 2.72539988 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 2.66079278 |
| 33 | Distal upper limb amyotrophy (HP:0007149) | 2.65036784 |
| 34 | Upper limb amyotrophy (HP:0009129) | 2.65036784 |
| 35 | Microcytic anemia (HP:0001935) | 2.64812908 |
| 36 | Lower limb amyotrophy (HP:0007210) | 2.64253528 |
| 37 | Onycholysis (HP:0001806) | 2.63986514 |
| 38 | Abnormality of renin-angiotensin system (HP:0000847) | 2.62290098 |
| 39 | Palmoplantar hyperkeratosis (HP:0000972) | 2.58525806 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 2.57663293 |
| 41 | Hypobetalipoproteinemia (HP:0003563) | 2.56730638 |
| 42 | Abnormality of binocular vision (HP:0011514) | 2.56685204 |
| 43 | Diplopia (HP:0000651) | 2.56685204 |
| 44 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.55748012 |
| 45 | Increased circulating renin level (HP:0000848) | 2.55006852 |
| 46 | Focal motor seizures (HP:0011153) | 2.50320015 |
| 47 | Spontaneous abortion (HP:0005268) | 2.49473769 |
| 48 | Xanthomatosis (HP:0000991) | 2.48640809 |
| 49 | Poikilocytosis (HP:0004447) | 2.48626529 |
| 50 | Hyperbilirubinemia (HP:0002904) | 2.46366614 |
| 51 | Acanthosis nigricans (HP:0000956) | 2.45987183 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 2.44701025 |
| 53 | Hypotrichosis (HP:0001006) | 2.44220174 |
| 54 | Axonal loss (HP:0003447) | 2.42103068 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.41928740 |
| 56 | Scanning speech (HP:0002168) | 2.41635290 |
| 57 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.39426670 |
| 58 | Epileptic encephalopathy (HP:0200134) | 2.34620876 |
| 59 | Nonprogressive disorder (HP:0003680) | 2.34062013 |
| 60 | Prolonged partial thromboplastin time (HP:0003645) | 2.34034010 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.33501893 |
| 62 | Focal seizures (HP:0007359) | 2.32387061 |
| 63 | Milia (HP:0001056) | 2.31741504 |
| 64 | Palmar hyperkeratosis (HP:0010765) | 2.31271521 |
| 65 | Increased serum ferritin (HP:0003281) | 2.29452019 |
| 66 | Decreased circulating renin level (HP:0003351) | 2.28372136 |
| 67 | Metabolic alkalosis (HP:0200114) | 2.24225308 |
| 68 | Renal salt wasting (HP:0000127) | 2.23897243 |
| 69 | Pili torti (HP:0003777) | 2.23518537 |
| 70 | Glomerulosclerosis (HP:0000096) | 2.23238566 |
| 71 | Abnormality of chloride homeostasis (HP:0011422) | 2.20995577 |
| 72 | Plantar hyperkeratosis (HP:0007556) | 2.20945239 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.20679290 |
| 74 | Abnormal number of erythroid precursors (HP:0012131) | 2.20447982 |
| 75 | Pustule (HP:0200039) | 2.20214273 |
| 76 | Spastic gait (HP:0002064) | 2.18129393 |
| 77 | Erythema (HP:0010783) | 2.17628931 |
| 78 | Hyperaldosteronism (HP:0000859) | 2.17278615 |
| 79 | Polygenic inheritance (HP:0010982) | 2.16902507 |
| 80 | Fatigue (HP:0012378) | 2.16888115 |
| 81 | Ketosis (HP:0001946) | 2.15504486 |
| 82 | Hemorrhage of the eye (HP:0011885) | 2.14369712 |
| 83 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.14274535 |
| 84 | Cerebral aneurysm (HP:0004944) | 2.14269081 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13292737 |
| 86 | Abnormal eating behavior (HP:0100738) | 2.12989861 |
| 87 | Dysmetria (HP:0001310) | 2.12620479 |
| 88 | Rapidly progressive (HP:0003678) | 2.10146955 |
| 89 | Muscle fiber splitting (HP:0003555) | 2.09565873 |
| 90 | Febrile seizures (HP:0002373) | 2.09545755 |
| 91 | Lip pit (HP:0100267) | 2.09493362 |
| 92 | Exercise-induced myalgia (HP:0003738) | 2.09336033 |
| 93 | Delayed CNS myelination (HP:0002188) | 2.06309926 |
| 94 | Hypokalemic alkalosis (HP:0001949) | 2.03939861 |
| 95 | Broad face (HP:0000283) | 2.03468762 |
| 96 | Dehydration (HP:0001944) | 2.02296584 |
| 97 | Esophageal varix (HP:0002040) | 2.02056478 |
| 98 | Onion bulb formation (HP:0003383) | 2.01753054 |
| 99 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.01518811 |
| 100 | Increased IgE level (HP:0003212) | 2.01275656 |
| 101 | Hypercholesterolemia (HP:0003124) | 1.99376139 |
| 102 | Spinal canal stenosis (HP:0003416) | 1.99271429 |
| 103 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.97833088 |
| 104 | Hyperkalemia (HP:0002153) | 1.97109642 |
| 105 | Papilledema (HP:0001085) | 1.96333764 |
| 106 | Foot dorsiflexor weakness (HP:0009027) | 1.94505886 |
| 107 | Abnormal atrioventricular conduction (HP:0005150) | 1.94380878 |
| 108 | Focal segmental glomerulosclerosis (HP:0000097) | 1.93239159 |
| 109 | Villous atrophy (HP:0011473) | 1.93164526 |
| 110 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.93164526 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 1.92959773 |
| 112 | Sleep apnea (HP:0010535) | 1.91698996 |
| 113 | Fat malabsorption (HP:0002630) | 1.91665093 |
| 114 | Hyperammonemia (HP:0001987) | 1.91427613 |
| 115 | Neuronal loss in central nervous system (HP:0002529) | 1.90932154 |
| 116 | Postural instability (HP:0002172) | 1.90866710 |
| 117 | Spastic diplegia (HP:0001264) | 1.90127161 |
| 118 | Neonatal onset (HP:0003623) | 1.89275980 |
| 119 | Joint hemorrhage (HP:0005261) | 1.87382740 |
| 120 | Growth hormone excess (HP:0000845) | 1.86933035 |
| 121 | Heart block (HP:0012722) | 1.86641417 |
| 122 | Torticollis (HP:0000473) | 1.86262642 |
| 123 | Abnormal hair laboratory examination (HP:0003328) | 1.86093423 |
| 124 | Turricephaly (HP:0000262) | 1.85863396 |
| 125 | Abnormality of the periventricular white matter (HP:0002518) | 1.85543984 |
| 126 | Erythroderma (HP:0001019) | 1.83761811 |
| 127 | Malnutrition (HP:0004395) | 1.83555363 |
| 128 | Adrenal overactivity (HP:0002717) | 1.83429223 |
| 129 | Alopecia of scalp (HP:0002293) | 1.83115772 |
| 130 | Abnormality of purine metabolism (HP:0004352) | 1.81412604 |
| 131 | Hyperacusis (HP:0010780) | 1.80498092 |
| 132 | Visual hallucinations (HP:0002367) | 1.80302164 |
| 133 | Nemaline bodies (HP:0003798) | 1.79249808 |
| 134 | Loss of speech (HP:0002371) | 1.78932267 |
| 135 | Difficulty running (HP:0009046) | 1.78846037 |
| 136 | Woolly hair (HP:0002224) | 1.78738728 |
| 137 | Lower limb asymmetry (HP:0100559) | 1.78552283 |
| 138 | Abnormality of the lumbar spine (HP:0100712) | 1.78468501 |
| 139 | Aplastic anemia (HP:0001915) | 1.78221513 |
| 140 | Ventricular fibrillation (HP:0001663) | 1.78164211 |
| 141 | Abnormal gallbladder physiology (HP:0012438) | 1.77677918 |
| 142 | Cholecystitis (HP:0001082) | 1.77677918 |
| 143 | Hyporeflexia of lower limbs (HP:0002600) | 1.77255481 |
| 144 | Abnormality of the common coagulation pathway (HP:0010990) | 1.76751309 |
| 145 | Parakeratosis (HP:0001036) | 1.75954856 |
| 146 | Spastic paraparesis (HP:0002313) | 1.75894280 |
| 147 | Polar cataract (HP:0010696) | 1.75543380 |
| 148 | Bronchomalacia (HP:0002780) | 1.74791446 |
| 149 | Nail dystrophy (HP:0008404) | 1.74464766 |
| 150 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.73955028 |
| 151 | Intention tremor (HP:0002080) | 1.73409032 |
| 152 | Acute myeloid leukemia (HP:0004808) | 1.73399893 |
| 153 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.73398244 |
| 154 | Cholelithiasis (HP:0001081) | 1.73116366 |
| 155 | Complement deficiency (HP:0004431) | 1.73041197 |
| 156 | Muscle fiber inclusion bodies (HP:0100299) | 1.72885646 |
| 157 | Stridor (HP:0010307) | 1.72337792 |
| 158 | Abnormality of the salivary glands (HP:0010286) | 1.72329025 |
| 159 | Abnormality of the foot musculature (HP:0001436) | 1.71963879 |
| 160 | Limb dystonia (HP:0002451) | 1.71621596 |
| 161 | Rigidity (HP:0002063) | 1.70951583 |
| 162 | Lymphangioma (HP:0100764) | 1.70831672 |
| 163 | Corneal erosion (HP:0200020) | 1.70688041 |
| 164 | Clonus (HP:0002169) | 1.70538195 |
| 165 | Cerebral hemorrhage (HP:0001342) | 1.69780548 |
| 166 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69356044 |
| 167 | Right ventricular cardiomyopathy (HP:0011663) | 1.68568882 |
| 168 | Broad metatarsal (HP:0001783) | 1.68228651 |
| 169 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.68147488 |
| 170 | Steatorrhea (HP:0002570) | 1.67968975 |
| 171 | Atrioventricular block (HP:0001678) | 1.67033937 |
| 172 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.66917282 |
| 173 | Ankle clonus (HP:0011448) | 1.66840302 |
| 174 | Thoracic kyphosis (HP:0002942) | 1.65452129 |
| 175 | Stroke (HP:0001297) | 1.65383631 |
| 176 | Gastrointestinal inflammation (HP:0004386) | 1.65132879 |
| 177 | Bruising susceptibility (HP:0000978) | 1.64136593 |
| 178 | Visceral angiomatosis (HP:0100761) | 1.63828179 |
| 179 | Cardiomegaly (HP:0001640) | 1.63547863 |
| 180 | IgM deficiency (HP:0002850) | 1.62833779 |
| 181 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.62819064 |
| 182 | Hemangiomatosis (HP:0007461) | 1.62346125 |
| 183 | Reduced antithrombin III activity (HP:0001976) | 1.61752136 |
| 184 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.60933384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.66007654 |
| 2 | MST1R | 3.49307084 |
| 3 | BCKDK | 3.09295195 |
| 4 | TGFBR2 | 2.97830778 |
| 5 | EEF2K | 2.79615117 |
| 6 | EPHB1 | 2.52112153 |
| 7 | PKN2 | 2.45611933 |
| 8 | MAPKAPK5 | 2.40868105 |
| 9 | LMTK2 | 2.27204006 |
| 10 | PRPF4B | 2.25723499 |
| 11 | CDK19 | 2.24796852 |
| 12 | MATK | 2.21648357 |
| 13 | TNIK | 2.13914468 |
| 14 | TGFBR1 | 2.03227894 |
| 15 | KDR | 2.01908457 |
| 16 | MAP4K1 | 1.97687081 |
| 17 | KIT | 1.97044075 |
| 18 | ERN1 | 1.88788327 |
| 19 | MAP2K3 | 1.84539735 |
| 20 | TRIB3 | 1.78610846 |
| 21 | PRKD3 | 1.73543369 |
| 22 | MAP3K7 | 1.69002414 |
| 23 | PAK6 | 1.68989416 |
| 24 | FES | 1.63694223 |
| 25 | NTRK1 | 1.59786725 |
| 26 | MAP3K6 | 1.58275648 |
| 27 | BTK | 1.55398182 |
| 28 | MUSK | 1.45779484 |
| 29 | SIK1 | 1.45341944 |
| 30 | MAP3K9 | 1.37991142 |
| 31 | MARK1 | 1.37234440 |
| 32 | FER | 1.36211896 |
| 33 | LRRK2 | 1.33757286 |
| 34 | MET | 1.31912657 |
| 35 | OXSR1 | 1.31367079 |
| 36 | MAPK15 | 1.28600462 |
| 37 | MAPKAPK3 | 1.27559299 |
| 38 | PIK3CG | 1.26981366 |
| 39 | PTK6 | 1.26547169 |
| 40 | UHMK1 | 1.21920693 |
| 41 | MAP3K11 | 1.20085548 |
| 42 | TAOK3 | 1.19084646 |
| 43 | SGK494 | 1.17360121 |
| 44 | SGK223 | 1.17360121 |
| 45 | PHKG1 | 1.16872661 |
| 46 | PHKG2 | 1.16872661 |
| 47 | MINK1 | 1.13798184 |
| 48 | RIPK4 | 1.12281486 |
| 49 | FGFR4 | 1.10003926 |
| 50 | NME2 | 1.09115105 |
| 51 | RET | 1.08553215 |
| 52 | MAP3K1 | 1.07009806 |
| 53 | TAOK1 | 1.06952424 |
| 54 | RPS6KB2 | 1.06900602 |
| 55 | FLT3 | 1.06181826 |
| 56 | RIPK1 | 1.05377635 |
| 57 | MAP2K6 | 1.03326538 |
| 58 | PRKG2 | 1.00806412 |
| 59 | IRAK2 | 1.00382203 |
| 60 | MAP3K2 | 0.99023511 |
| 61 | MAP2K4 | 0.98735082 |
| 62 | CAMK1 | 0.98678486 |
| 63 | NTRK3 | 0.98433881 |
| 64 | ICK | 0.97351699 |
| 65 | GRK5 | 0.95401458 |
| 66 | LATS2 | 0.93441714 |
| 67 | MARK2 | 0.90252216 |
| 68 | TTN | 0.87718853 |
| 69 | STK39 | 0.85408651 |
| 70 | EPHA4 | 0.85283441 |
| 71 | PINK1 | 0.84852641 |
| 72 | SGK3 | 0.83352649 |
| 73 | CAMKK1 | 0.82946046 |
| 74 | CDK5 | 0.81004002 |
| 75 | TESK1 | 0.80446212 |
| 76 | PDK1 | 0.79479366 |
| 77 | JAK3 | 0.78860707 |
| 78 | TBK1 | 0.77592361 |
| 79 | CSNK1G3 | 0.77419260 |
| 80 | WNK4 | 0.76375416 |
| 81 | EPHA2 | 0.75555861 |
| 82 | PRKD2 | 0.74129843 |
| 83 | CSNK1G2 | 0.72007020 |
| 84 | JAK2 | 0.70954065 |
| 85 | STK38 | 0.69211916 |
| 86 | CSF1R | 0.69032981 |
| 87 | PAK4 | 0.69007093 |
| 88 | SGK2 | 0.68917984 |
| 89 | PDPK1 | 0.67672318 |
| 90 | TYRO3 | 0.66507620 |
| 91 | PRKAA2 | 0.65999554 |
| 92 | MAP3K12 | 0.65934554 |
| 93 | EPHB2 | 0.64718245 |
| 94 | TNK2 | 0.63080435 |
| 95 | NTRK2 | 0.62716194 |
| 96 | HIPK2 | 0.61569520 |
| 97 | CSNK1G1 | 0.61425224 |
| 98 | PRKCH | 0.60839094 |
| 99 | TRPM7 | 0.60718120 |
| 100 | CDK12 | 0.60362956 |
| 101 | TEC | 0.60190067 |
| 102 | PIK3CA | 0.59623056 |
| 103 | PTK2B | 0.59264922 |
| 104 | ZAP70 | 0.58885098 |
| 105 | BMX | 0.58796357 |
| 106 | WNK1 | 0.57880246 |
| 107 | IRAK3 | 0.57077518 |
| 108 | MAPK4 | 0.56518358 |
| 109 | SGK1 | 0.55190125 |
| 110 | DAPK1 | 0.55099758 |
| 111 | STK11 | 0.55057428 |
| 112 | SYK | 0.54709071 |
| 113 | HCK | 0.54519319 |
| 114 | CAMK2G | 0.52625399 |
| 115 | SMG1 | 0.51760054 |
| 116 | MAP3K3 | 0.51364349 |
| 117 | MTOR | 0.50993963 |
| 118 | MAPK11 | 0.50278745 |
| 119 | PRKD1 | 0.49906798 |
| 120 | CSNK1A1L | 0.49462246 |
| 121 | MAPK7 | 0.48665795 |
| 122 | PKN1 | 0.48621202 |
| 123 | CAMKK2 | 0.48177014 |
| 124 | SIK2 | 0.47825484 |
| 125 | CDC42BPA | 0.46513251 |
| 126 | KSR2 | 0.45338970 |
| 127 | DAPK2 | 0.45263687 |
| 128 | DAPK3 | 0.44358190 |
| 129 | MAPK12 | 0.43807169 |
| 130 | NME1 | 0.42914543 |
| 131 | CCNB1 | 0.42700241 |
| 132 | CLK1 | 0.42401107 |
| 133 | PIM2 | 0.41982318 |
| 134 | CAMK2D | 0.41909545 |
| 135 | PAK2 | 0.41628716 |
| 136 | STK16 | 0.41406951 |
| 137 | MAPK10 | 0.40069261 |
| 138 | PTK2 | 0.37826992 |
| 139 | ERBB2 | 0.34529025 |
| 140 | CAMK2B | 0.34272672 |
| 141 | ALK | 0.34193659 |
| 142 | FGFR3 | 0.33862570 |
| 143 | RPS6KA2 | 0.32778676 |
| 144 | MAP3K13 | 0.32132308 |
| 145 | CAMK1G | 0.31248933 |
| 146 | MAP2K7 | 0.31159341 |
| 147 | FGFR2 | 0.30684712 |
| 148 | SRC | 0.30047388 |
| 149 | MAP2K2 | 0.29896739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.27792937 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.21009023 |
| 3 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.77979106 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.51198128 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.46493780 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35777196 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.24152839 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.13703199 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.10221803 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.93178605 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.91645412 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89364875 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.86315154 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79319001 |
| 15 | Platelet activation_Homo sapiens_hsa04611 | 1.74935881 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72667911 |
| 17 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.70024866 |
| 18 | ABC transporters_Homo sapiens_hsa02010 | 1.64488602 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.62077169 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.60061725 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.55478633 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.55187410 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54043458 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.53927440 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.48230112 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47173778 |
| 27 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.45777787 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.41031845 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38051206 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36982300 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33955713 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.33721197 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26628552 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25554835 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.23695728 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.22597293 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.21720747 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21198093 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.21028855 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20259625 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20259108 |
| 42 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.16951876 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.16409008 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14691091 |
| 45 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12478013 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12456344 |
| 47 | Morphine addiction_Homo sapiens_hsa05032 | 1.11259225 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09415348 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07837816 |
| 50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.05594979 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05523651 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05322782 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04624978 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04105263 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02595366 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99472487 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98607044 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98058627 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.97341009 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95270861 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92990937 |
| 62 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91529415 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.90237639 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89874545 |
| 65 | Salivary secretion_Homo sapiens_hsa04970 | 0.89669452 |
| 66 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89484883 |
| 67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.89361624 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88331203 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87382792 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87352826 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87139575 |
| 72 | Gap junction_Homo sapiens_hsa04540 | 0.86133646 |
| 73 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85280531 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85155526 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82215476 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79627178 |
| 77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.79046185 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78100995 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77641158 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77621895 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.77567266 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76365548 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.76229050 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75683521 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.74976190 |
| 86 | Tight junction_Homo sapiens_hsa04530 | 0.74910784 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74800614 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74432623 |
| 89 | Axon guidance_Homo sapiens_hsa04360 | 0.73762806 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73143523 |
| 91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72711874 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72611668 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72250335 |
| 94 | Circadian entrainment_Homo sapiens_hsa04713 | 0.71899044 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71865886 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71179347 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71102853 |
| 98 | Taste transduction_Homo sapiens_hsa04742 | 0.70412005 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68930256 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.67974323 |
| 101 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67841694 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67663828 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67499538 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67169904 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66954059 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65730330 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65413360 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65095363 |
| 109 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.64876882 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64395402 |
| 111 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63373263 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62061199 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61149853 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60297873 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59927389 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59759481 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59687915 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59250733 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58791484 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.55719928 |
| 121 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55589119 |
| 122 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55394076 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54667384 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54521790 |
| 125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53935870 |
| 126 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53154617 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52785400 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52661730 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52220054 |
| 130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52011267 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51059811 |
| 132 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51006682 |
| 133 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50606737 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.49534026 |
| 135 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47218202 |
| 136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43362503 |
| 137 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43283247 |
| 138 | Lysine degradation_Homo sapiens_hsa00310 | 0.42550282 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41939534 |
| 140 | Long-term depression_Homo sapiens_hsa04730 | 0.41831623 |
| 141 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41711544 |
| 142 | Amoebiasis_Homo sapiens_hsa05146 | 0.41392410 |
| 143 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41342073 |
| 144 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40859042 |
| 145 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37668919 |
| 146 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37433002 |
| 147 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37392613 |
| 148 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37363338 |
| 149 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37036188 |
| 150 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35958650 |
| 151 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35533595 |
| 152 | Shigellosis_Homo sapiens_hsa05131 | 0.35338174 |
| 153 | Renin secretion_Homo sapiens_hsa04924 | 0.34608692 |
| 154 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34049385 |
| 155 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33580917 |
| 156 | Endocytosis_Homo sapiens_hsa04144 | 0.33522409 |
| 157 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32384496 |
| 158 | GABAergic synapse_Homo sapiens_hsa04727 | 0.32209965 |
| 159 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30878727 |

